IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 40 filers reported holding IMPEL NEUROPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $860 | -66.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,540 | -9.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,800 | -65.1% | 2,000 | -6.6% | 0.00% | – |
| Q4 2022 | $8,033 | -85.4% | 2,142 | -81.4% | 0.00% | – |
| Q3 2022 | $55,000 | -62.1% | 11,519 | -26.5% | 0.00% | – |
| Q2 2022 | $145,000 | +107.1% | 15,666 | +41.0% | 0.00% | – |
| Q1 2022 | $70,000 | -33.3% | 11,112 | -8.0% | 0.00% | – |
| Q4 2021 | $105,000 | +34.6% | 12,079 | +90.3% | 0.00% | – |
| Q3 2021 | $78,000 | +13.0% | 6,349 | -19.5% | 0.00% | – |
| Q2 2021 | $69,000 | – | 7,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NVP Associates, LLC | 3,077,198 | $11,539,493 | 11.26% |
| Vivo Capital, LLC | 2,884,789 | $43,272 | 4.98% |
| venBio Partners LLC | 2,759,791 | $10,349,216 | 3.21% |
| 5AM Venture Management, LLC | 2,884,791 | $10,817,966 | 2.91% |
| LASRY MARC | 408,329 | $1,531,234 | 2.38% |
| DCF Advisers, LLC | 325,825 | $1,221,844 | 0.83% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $15,509,891 | 0.52% |
| EPIQ PARTNERS, LLC | 18,646 | $69,923 | 0.05% |
| J. Goldman & Co LP | 200,219 | $750,821 | 0.04% |
| MCDONALD PARTNERS LLC | 11,700 | $43,875 | 0.02% |